| （単位：千ドル） | 1Q20 | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 7,254 | 7,723 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 営業費用 | 9,179 | 11,123 | 25,602 | 16,553 | 21,057 | 18,456 | 23,258 | 20,696 | 25,694 | 25,678 | 24,992 | 28,682 | 28,990 | 36,017 | 38,318 | 32,718 |
| 営業利益 | -9,179 | -11,123 | -25,602 | -16,553 | -21,057 | -18,456 | -23,258 | -20,696 | -25,694 | -25,678 | -24,992 | -28,682 | -28,990 | -36,017 | -38,318 | -32,718 |
| 純利益 | -8,872 | -11,024 | -25,548 | -16,509 | -21,009 | -18,426 | -23,159 | -20,287 | -24,829 | -23,945 | -22,944 | -25,478 | -25,011 | -31,963 | -34,566 | -30,021 |
| 一株あたり利益 | - | - | - | - | - | - | - | -0.51 | -0.63 | -0.53 | -0.5 | -0.44 | -0.37 | -0.45 | -0.49 | -0.42 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | -0.51 | -0.63 | -0.53 | -0.5 | -0.44 | -0.37 | -0.45 | -0.49 | -0.42 |